[US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading ->
A transformation of global diets away from red meat consumption and towards healthier plant-based alternatives is critical for the world to combat climate change and land degradation that threatens food systems, while meeting the nutrition requirements of a growing population, says a new report by the Intergovernmental Panel on Climate Change (IPCC). The report, Climate […] Continue reading ->
There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading ->
Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading ->
An estimated 820 million people went hungry in 2018, the third continuous year in a worldwide trend of rising hunger. And over one-quarter of the world’s population, or 2 billion people in all, experienced moderate or severe food insecurity, according to the The State of Food Security and Nutrition in the World report for 2019. […] Continue reading ->